ProQR Therapeutics (PRQR) Receivables - Other (2016 - 2025)
ProQR Therapeutics' Receivables - Other history spans 6 years, with the latest figure at $364345.6 for Q4 2025.
- On a quarterly basis, Receivables - Other fell 59.17% to $364345.6 in Q4 2025 year-over-year; TTM through Dec 2025 was $364345.6, a 59.17% decrease, with the full-year FY2025 number at $364345.6, down 59.17% from a year prior.
- Receivables - Other hit $364345.6 in Q4 2025 for ProQR Therapeutics, down from $892277.2 in the prior quarter.
- Over the last five years, Receivables - Other for PRQR hit a ceiling of $892277.2 in Q4 2024 and a floor of $306584.2 in Q4 2021.
- Historically, Receivables - Other has averaged $549475.0 across 5 years, with a median of $382592.8 in 2022.
- Biggest five-year swings in Receivables - Other: soared 109.51% in 2023 and later crashed 59.17% in 2025.
- Tracing PRQR's Receivables - Other over 5 years: stood at $306584.2 in 2021, then increased by 24.79% to $382592.8 in 2022, then soared by 109.51% to $801575.2 in 2023, then rose by 11.32% to $892277.2 in 2024, then crashed by 59.17% to $364345.6 in 2025.
- Business Quant data shows Receivables - Other for PRQR at $364345.6 in Q4 2025, $892277.2 in Q4 2024, and $801575.2 in Q4 2023.